Compare LII & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LII | WST |
|---|---|---|
| Founded | 1895 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7B | 20.2B |
| IPO Year | 1999 | N/A |
| Metric | LII | WST |
|---|---|---|
| Price | $498.43 | $277.32 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $603.36 | $345.75 |
| AVG Volume (30 Days) | 452.0K | ★ 696.6K |
| Earning Date | 01-28-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.05% | 0.32% |
| EPS Growth | ★ 12.46 | 0.17 |
| EPS | ★ 23.67 | 6.75 |
| Revenue | ★ $5,345,300,000.00 | $3,017,900,000.00 |
| Revenue This Year | N/A | $7.01 |
| Revenue Next Year | $6.71 | $6.20 |
| P/E Ratio | ★ $21.01 | $40.98 |
| Revenue Growth | 3.77 | ★ 4.92 |
| 52 Week Low | $443.19 | $187.43 |
| 52 Week High | $689.44 | $348.90 |
| Indicator | LII | WST |
|---|---|---|
| Relative Strength Index (RSI) | 51.30 | 54.34 |
| Support Level | $486.81 | $264.92 |
| Resistance Level | $508.94 | $278.43 |
| Average True Range (ATR) | 11.54 | 6.74 |
| MACD | -0.15 | 0.66 |
| Stochastic Oscillator | 27.91 | 65.94 |
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.